WHO ICTRP trial
A randomized, open, pre - and post-treatment, and parallel - control study for…
ChiCTR1900025120 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1900025120 |
|---|---|
| Public title | A randomized, open, pre - and post-treatment, and parallel - control study for oral splenic aminopeptide solution for allergic rhinitis |
| Scientific title | A randomized, open, pre - and post-treatment, and parallel - control study for oral splenic aminopeptide solution for allergic rhinitis |
| Primary sponsor | Jiangsu Province Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Allergic rhinitis |
| Interventions | One:Oral liquid of spleen ammonia peptide;two:clarityne;three:Oral liquid of spleen ammonia peptide and clarityne |
| Registration date | Aug 12, 2019 |
| Target size | One:40;two:40;three:40 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: